Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Role of the Immune Environment in Response to Therapy in Breast Cancer

See Locations Near You

Summary

This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria:

Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.

Exclusion criteria:

Males Children Pregnant individuals

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT05396612

Recruitment Status:

Recruiting

Sponsor:

Abramson Cancer Center at Penn Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Abramson Cancer Center
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT05396612

Recruitment Status:

Recruiting

Sponsor:


Abramson Cancer Center at Penn Medicine

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.